Effect of Estradiol Cypionate in Postparturient Dairy Cattle at Increased Risk for Metritis

Authors

  • Michael W. Overton Veterinary Medicine Teaching and Research Center, University of California, Davis 95616
  • William M. Sischo Veterinary Medicine Teaching and Research Center, University of California, Davis 95616
  • James P. Reynolds Veterinary Medicine Teaching and Research Center, University of California, Davis 95616

DOI:

https://doi.org/10.21423/aabppro20015198

Keywords:

Metritis, Estradiol Cypionate, uterine disease, fetal membrane

Abstract

Metritis is a postparturient uterine disease that adversely affects fertility, milk production, and health of dairy cattle. Although few cows in most herds develop life-threatening septic metritis, many may develop anorexia secondary to metritis-related pyrexia. In an attempt to prevent or reduce the effects ofmetritis, many dairymen have adopted some form of a standardized fresh cow program that often includes administration of 4 mg Estradiol Cypionate (ECP) to postparturient cows with retained fetal membranes. Estradiol has been shown to stimulate uterine contractions, increase phagocytosis of bacteria, increase uterine blood flow, and enhance uterine immune function. However, data is not available to support the use of ECP for prevention of metritis. Recent work by Wagner, et al showed no benefit to the routine use of ECP in randomly assigned postparturient dairy cattle. However, this study contained relatively few cows with known risk factors for metritis. A study was conducted to determine whether the administration of 4 mg of ECP to cows at higher risk for metritis is efficacious in preventing or decreasing severity of metritis in the first 10 days postpartum.

Downloads

Published

2001-09-13

Issue

Section

Research Summaries - Dairy